Factors Associated with Progression of Carcinoid Heart Disease
- 13 March 2003
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 348 (11), 1005-1015
- https://doi.org/10.1056/nejmoa021451
Abstract
By releasing vasoactive substances into the circulation, carcinoid tumors can cause right-sided valvular heart disease. Factors associated with the progression of carcinoid heart disease are poorly understood. We conducted a retrospective study to identify such factors.Keywords
This publication has 22 references indexed in Scilit:
- Carcinoid TumorsNew England Journal of Medicine, 1999
- OctreotideNew England Journal of Medicine, 1996
- Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.Journal of Clinical Investigation, 1994
- Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and VomitingNew England Journal of Medicine, 1990
- Serotonin stimulates DNA synthesis in fibroblasts acting through 5–HT1B receptors coupled to a Gi-proteinNature, 1988
- Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities.Circulation, 1988
- Cytotoxic Treatment in Patients with Malignant Carcinoid Tumors: Response to streptozocin—alone or in combination with 5-FUActa Oncologica, 1987
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Detection and evaluation of tricuspid regurgitation using a real-time, two-dimensional, color-coded, Doppler flow imaging system: Comparison with contrast two-dimensional echocardiography and right ventriculographyThe American Journal of Cardiology, 1986
- Assessment of tricuspid regurgitation by pulsed doppler ultrasonography of the hepatic veinsThe American Journal of Cardiology, 1984